000			01534aam a2200409 i 4500
005			20250914164840.0
006			m d
007			cr nn 008maaau
008			090212s2006 gw j eng d
020			_a9783540376507 (electronic bk.)
035			_a(Springer)978-3-540-30982-6
039		9	_a200902121947 _bmuhaimin _y04-04-2008 _zmuhaimin
050	0	0	_aRS431.A6 _bH68 2006
082	0	0	_a615.329 _222
245	0	0	_aHeterocyclic Antitumor Antibiotics _h[electronic resource] / _cedited by Moses Lee.
260			_aBerlin Heidelberg : _bSpringer-Verlag GmbH., _c2006
300			_a1online resource (x, 252 p.) : _bill., digital ; _c25 cm.
440		0	_aTopics in Heterocyclic Chemistry, _x1861-9282 ; _v2
650		0	_aAntineoplastic agents.
650		0	_aAntibiotics.
650		0	_aAntibacterial agents.
650		0	_aPyrroles _xTherapeutic use.
650		0	_aCarbolines _xTherapeutic use.
650		0	_aDiazo compounds _xTherapeutic use.
650		0	_aBeta lactamases _xInhibitors _xTherapeutic use.
650		0	_aHeterocyclic chemistry.
700	1		_aLee, Moses.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer e-books
856	4	0	_uhttps://eresourcesptsl.ukm.remotexs.co/user/login?url=http://dx.doi.org/10.1007/11413073
907			_a.b14141930 _b2024-11-26 _c2019-11-12
942			_n0
914			_avtls003371751
998			_ae0001 _b2008-04-04 _cm _dz _feng _ggw _y0 _z.b14141930
999			_c410173 _d410173